Literature DB >> 27732807

More on Reevaluating PSA Testing Rates in the PLCO Trial.

Paul Pinsky1, Philip Prorok1.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27732807     DOI: 10.1056/NEJMc1607379

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Prostate Cancer Screening.

Authors:  William J Catalona
Journal:  Med Clin North Am       Date:  2018-03       Impact factor: 5.456

2.  Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.

Authors:  Paul F Pinsky; Philip C Prorok; Kelly Yu; Barnett S Kramer; Amanda Black; John K Gohagan; E David Crawford; Robert L Grubb; Gerald L Andriole
Journal:  Cancer       Date:  2016-12-01       Impact factor: 6.860

Review 3.  Prostate Cancer: Update on Early Detection and New Biomarkers.

Authors:  Robert L Grubb
Journal:  Mo Med       Date:  2018 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.